Change search
ReferencesLink to record
Permanent link

Direct link
Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Show others and affiliations
2012 (English)In: Molecular Oncology, ISSN 1574-7891, Vol. 6, no 3, 333-346 p.Article in journal (Refereed) Published
Abstract [en]

The Shb adapter protein is a signaling intermediate that operates downstream of vascular endothelial growth factor receptor-2 (VEGFR-2) in endothelial cells. The Shb knockout mouse displays a dysfunctional microvasculature and impaired growth of subcutaneously implanted tumor cells. We decided to investigate tumor growth and angiogenesis in the absence of Shb in an inheritable tumor model, the RIP-Tag2 mouse, which produces insulinomas in a manner highly dependent on de novo angiogenesis. We observed a reduced tumor incidence and burden in both RIP-Tag2 Shb-/- and RIP-Tag2 Shb+/- mice. This correlated with a reduced microvascular density, measured as percentage of insulinoma area positive for CD31 staining, and altered vascular morphology. However, treatment with a VEGF-A blocking antibody was without effect on the Shb mutant tumor volume whereas it significantly inhibited tumor volume in the wild-type mice, suggesting that in mice with reduced Shb expression tumor angiogenesis was primarily sustained by VEGF-A independent pathway(s). This notion was further substantiated by gene expression analysis of angiogenic markers showing reduced VEGF-A expression in Shb deficient tumors. Considerable heterogeneity with respect to the gene expression profiles of other angiogenic markers and the signal-transduction characteristics was observed between different tumors, suggesting that multiple “rescue” pathways could be operating. The numbers of invasive tumors or metastases were unchanged in the Shb mutant. It is concluded that the Shb mutant background reduces tumor frequency by chronically suppressing VEGF-A dependent angiogenesis. However, VEGF-A independent angiogenesis supports a significant degree of tumor expansion in Shbdeficient mice, indicating heterogeneity in the mechanisms by which tumor expansion is promoted. Interference with Shb signaling may provide novel means for future cancer therapy.

Place, publisher, year, edition, pages
2012. Vol. 6, no 3, 333-346 p.
Keyword [en]
insulinomas, Shb, angiogenesis, VEGF
National Category
Cell and Molecular Biology
URN: urn:nbn:se:uu:diva-167253DOI: 10.1016/j.molonc.2012.01.006ISI: 000305374900007OAI: diva2:482453
Available from: 2012-01-24 Created: 2012-01-24 Last updated: 2012-08-02Bibliographically approved

Open Access in DiVA

fulltext(10847 kB)206 downloads
File information
File name FULLTEXT01.pdfFile size 10847 kBChecksum SHA-512
Type fulltextMimetype application/pdf
supplemental data(35465 kB)45 downloads
File information
File name ATTACHMENT01.pdfFile size 35465 kBChecksum SHA-512
Type attachmentMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Åkerblom, BjörnZang, GuangxiangCalounova, GabrielaWelsh, Michael
By organisation
Department of Medical Cell Biology
In the same journal
Molecular Oncology
Cell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 206 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 342 hits
ReferencesLink to record
Permanent link

Direct link